Molly Henderson Uro Gen Pharma Ltd. (URGN) insider trading activity

URGN Quotes by TradingView

Molly Henderson is Chief Financial Officer of UroGen Pharma Ltd.. Currently has a direct ownership of 5,248 shares of URGN, which is worth approximately $59,302. The most recent transaction as insider was on Jan 31, 2022, when has been sold 331 shares (Ordinary Shares) at a price of $7.58 per share, resulting in proceeds of $2,509. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.25K
0% 3M change
0% 12M change
Total Value Held $59,302

Molly Henderson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2022
SELL
Open market or private sale
$2,509 $7.58 p/Share
331 Reduced 5.93%
5,248 Ordinary Shares
Jan 31 2022
BUY
Exercise of conversion of derivative security
-
666 Added 10.66%
5,579 Ordinary Shares
Nov 30 2021
SELL
Open market or private sale
$31,122 $12.03 p/Share
2,587 Reduced 34.49%
4,913 Ordinary Shares
Nov 30 2021
BUY
Exercise of conversion of derivative security
-
5,000 Added 40.0%
7,500 Ordinary Shares
May 17 2021
BUY
Open market or private purchase
$39,625 $15.85 p/Share
2,500 Added 50.0%
2,500 Common Stock

Also insider at

PHAT
Phathom Pharmaceuticals, Inc. Healthcare
CFO and CBO
MH

Molly Henderson

Chief Financial Officer
Florham, NJ

Track Institutional and Insider Activities on URGN

Follow UroGen Pharma Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells URGN shares.

Notify only if

Insider Trading

Get notified when an Uro Gen Pharma Ltd. insider buys or sells URGN shares.

Notify only if

News

Receive news related to UroGen Pharma Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on URGN